{
    "title": "U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11391599/U-S-Supreme-Court-hear-Amgen-bid-revive-cholesterol-drug-patents.html",
    "date": "2022-11-04",
    "keywords": [
        "court",
        "amgen",
        "sanofi",
        "repatha",
        "regeneron",
        "praluent",
        "spokesperson",
        "decision",
        "patent",
        "worth",
        "year",
        "blake",
        "brittain",
        "washington",
        "cholesterol",
        "drug",
        "case",
        "approval",
        "industry",
        "heart",
        "circuit",
        "brief",
        "co",
        "bid",
        "challenge",
        "appeal",
        "ruling",
        "test",
        "ability",
        "mechanism",
        "antibody",
        "company",
        "firmly",
        "validity",
        "protection",
        "biotechnology",
        "companys",
        "belief",
        "end",
        "june",
        "request",
        "comment",
        "worldwide",
        "protein",
        "pcsk9",
        "removal",
        "blood",
        "risk",
        "disease",
        "drugmaker",
        "partner",
        "rest",
        "world",
        "delaware",
        "judge",
        "jury",
        "verdict",
        "favor",
        "law",
        "person",
        "experimentation",
        "type",
        "genus",
        "impact",
        "biotech",
        "support",
        "biogen",
        "inc",
        "bristol",
        "merck",
        "amp",
        "pace",
        "research",
        "development",
        "hinder",
        "innovation",
        "detriment",
        "public",
        "administration",
        "reporting",
        "raymond",
        "boston",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}